UNSPSC 41202032: Histoplasma capsulatumserological reagents

In this classification, Histoplasma capsulatum serological reagents are devices used in test to identify specific Histoplasma capsulatum antibodies in serum. US FDA regulates Histoplasma capsulatum serological reagents under 21 CFR 866.3320 and under FDA product code GMJ.

UNSPSC 41202032 Histoplasma capsulatum serological reagents is a Commodity code that in practice covers a much broader range of infectious-disease screening and diagnostic testing services than its nominal scope suggests. State and local health departments, criminal justice agencies, and public health systems are actually procuring HIV, Syphilis, and Hepatitis testing reagents; specimen collection and drug-testing services; and related laboratory diagnostic infrastructure through solicitations tagged to this code. The work encompasses rapid point-of-care test kits (such as Abbott Determine HIV combo tests), automated multi-analyte screening platforms with instrument and reagent bundling, immunoassay screening with confirmatory testing by LC/MS/MS or GC/MS, and associated laboratory support services including result reporting, quality controls, and maintenance contracts. Issuing bodies span state health departments (Illinois Department of Public Health, Texas Department of Criminal Justice), county criminal-justice agencies (Collin County Community Supervision and Corrections Department), municipal public health programs (City of Austin), and university health centers (University of Houston).

Recent procurement activity clusters in Illinois and Texas. The Illinois Department of Public Health has issued multiple emergency sole-source procurements to Abbott Laboratories for HIV and Syphilis reagents and ARCHITECT analyzer consumables (contracts of $38,079.50 each, posted February and May 2026), and an Invitation for Bid for a five-year, multi-analyte screening contract covering Hepatitis B, Hepatitis C, HIV-1/HIV-2, and Syphilis assays with automated instrumentation (due March 16, 2026). Collin County is soliciting offender specimen collection and drug testing services under RFP 2026-327 (due July 23, 2026) for approximately 25,031 annual tests at an estimated contract value of $600,000 over two years. The City of Austin issued IFB 9100AAM1023 for rapid HIV test kits (due July 17, 2026), and the Texas Department of Criminal Justice posted forensic analysis and laboratory testing solicitations (RFP 696-IG-26-P034, due May 13, 2026) requiring accreditation in serology and DNA testing. The University of Houston sought clinical diagnostic laboratory services including blood chemistry reagents through RFP-730-UofH-3109 (due March 24, 2026). The code shows sustained activity driven by public health surveillance, criminal justice monitoring, and routine clinical screening demands, though the mismatch between the nominal code name and actual scope suggests this commodity is underutilized as a classification category within state and local procurement systems.